A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes
Status:
Not yet recruiting
Trial end date:
2024-08-30
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to compare the effect of the addition of tirzepatide or
placebo to titrated basal insulin on glycemic control in Chinese participants with type 2
diabetes.